Greater Cannabis Company, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Greater Cannabis Company, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $7.1K | Apr 14, 2020 |
| FY2019 | Dec 31, 2018 | $95.4K | Apr 14, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $12.6K | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | $48.0K | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $7.1K | Mar 26, 2021 |
| FY2018 | Dec 31, 2018 | $95.4K | Apr 15, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $209 | Apr 26, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | ($25) | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | ($46) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $4.0K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $86.9K | Apr 14, 2020 |
| FY2017 | Dec 31, 2017 | $100 | Apr 26, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($331.6K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($179.0K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($188.4K) | May 5, 2025 |
| FY2023 | Dec 31, 2022 | ($360.3K) | Apr 1, 2024 |
| FY2021 | Dec 31, 2021 | ($196.3K) | Apr 12, 2022 |
| FY2021 | Sep 30, 2021 | ($252.3K) | Apr 12, 2022 |
| FY2021 | Jun 30, 2021 | ($39.0K) | Apr 12, 2022 |
| FY2021 | Mar 31, 2021 | ($114.7K) | Apr 12, 2022 |
| FY2021 | Dec 31, 2020 | ($382.8K) | Apr 12, 2022 |
| FY2021 | Sep 30, 2020 | ($459.3K) | Apr 12, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($183.0K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($156.3K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($175.4K) | May 5, 2025 |
| FY2023 | Dec 31, 2022 | ($177.0K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($343.1K) | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | ($294.5K) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($525.3K) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($190.9K) | Apr 14, 2020 |
| FY2017 | Dec 31, 2017 | ($622.6K) | Apr 26, 2018 |
| FY2017 | Dec 31, 2016 | ($100.0K) | Apr 26, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($60.2K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($109.5K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($103.2K) | May 5, 2025 |
| FY2023 | Dec 31, 2022 | ($107.5K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($235.4K) | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | ($289.6K) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($285.2K) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($100.1K) | Apr 14, 2020 |
| FY2017 | Dec 31, 2017 | ($36.3K) | Apr 26, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $815 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $57.8K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $172.3K | May 5, 2025 |
| FY2023 | Dec 31, 2022 | $280.4K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $392.9K | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | $180.1K | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $52.7K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $149.6K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $0 | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Apr 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $742.5K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $898.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $833.5K | May 5, 2025 |
| FY2023 | Dec 31, 2022 | $825.3K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $862.0K | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | $459.9K | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $1.60M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $713.4K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $0 | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $108.8K | Apr 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($741.6K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($840.3K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($661.2K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($544.8K) | May 5, 2025 |
| FY2023 | Dec 31, 2021 | ($469.1K) | Apr 1, 2024 |
| FY2021 | Sep 30, 2021 | ($272.7K) | Apr 12, 2022 |
| FY2021 | Jun 30, 2021 | ($86.5K) | Apr 12, 2022 |
| FY2021 | Mar 31, 2021 | ($348.9K) | Apr 12, 2022 |
| FY2022 | Dec 31, 2020 | ($279.8K) | Apr 13, 2023 |
| FY2021 | Sep 30, 2020 | ($701.3K) | Apr 12, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.99M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($4.66M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($4.48M) | May 5, 2025 |
| FY2023 | Dec 31, 2022 | ($4.29M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($3.93M) | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | ($3.33M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($2.38M) | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | ($839.1K) | Apr 14, 2020 |
| FY2017 | Dec 31, 2017 | ($916.0K) | Apr 26, 2018 |
| FY2017 | Dec 31, 2016 | ($108.8K) | Apr 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $166.9K | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | $270.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $377.5K | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | $113.0K | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $24.7K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $59.9K | Apr 14, 2020 |
| FY2017 | Dec 31, 2017 | $993 | Apr 26, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | May 5, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 13, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | May 5, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 944,935 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 536,622 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 804.64M | May 5, 2025 |
| FY2023 | Dec 31, 2022 | 732.64M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 508.64M | Apr 13, 2023 |
| FY2021 | Dec 31, 2020 | 464.84M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | 39.30M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 31.88M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 26.91M | Apr 26, 2018 |